First Time Loading...

Inhibikase Therapeutics Inc
NASDAQ:IKT

Watchlist Manager
Inhibikase Therapeutics Inc Logo
Inhibikase Therapeutics Inc
NASDAQ:IKT
Watchlist
Price: 1.39 USD 3.73% Market Closed
Updated: May 5, 2024
Section:
 

Wall Street
Price Targets

IKT Price Targets Summary
Inhibikase Therapeutics Inc

There are no price targets for IKT.
IKT Lowest Forecast
Wall Street Target
Not Available
IKT Average Forecast
Wall Street Target
Not Available
IKT Highest Forecast
Wall Street Target
Not Available
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
Inhibikase Therapeutics Inc Competitors:
Price Targets
BNTX
BioNTech SE
30% Upside
M
MLYS
Mineralys Therapeutics Inc
166% Upside
C
CBUS
Cibus Inc
38% Upside
603392
Beijing Wantai Biological Pharmacy Enterprise Co Ltd
1% Downside
BNTX
BioNTech SE
30% Upside
M
MLYS
Mineralys Therapeutics Inc
166% Upside
C
CBUS
Cibus Inc
38% Upside
603392
Beijing Wantai Biological Pharmacy Enterprise Co Ltd
1% Downside
W
300142
Walvax Biotechnology Co Ltd
39% Upside
002007
Hualan Biological Engineering Inc
35% Upside
GLPG
Galapagos NV
55% Upside
XOMA
XOMA Corp
135% Upside

Revenue
Forecast

Revenue Estimate
Inhibikase Therapeutics Inc

For the last 6 years the compound annual growth rate for Inhibikase Therapeutics Inc's revenue is -29%. The projected CAGR for the next 3 years is 222%.

-29%
Past Growth
222%
Estimated Growth
Estimates Accuracy
-1%
Average Miss
What are analyst estimates?

Operating Income
Forecast

Operating Income Estimate
Inhibikase Therapeutics Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-3%
Average Miss
What are analyst estimates?

Net Income
Forecast

Net Income Estimate
Inhibikase Therapeutics Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-39%
Average Miss
What are analyst estimates?

See Also

Summary
IKT intrinsic value, competitors valuation, and company profile.
DCF Valuation
IKT stock valuation using Discount Cash Flow valuation method.
Relative Valuation
IKT stock valuation using valuation multiples.
Wall Street Estimates
IKT price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
IKT stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is IKT's stock price target?
Not Available

IKT doesn't have any price targets made by Wall Street professionals.

What is Inhibikase Therapeutics Inc's Revenue forecast?
Projected CAGR
222%

For the last 6 years the compound annual growth rate for Inhibikase Therapeutics Inc's revenue is -29%. The projected CAGR for the next 3 years is 222%.

ALPHA SPREAD
Join more than 134,400+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.